Zu‐Xi Yu

6.0k citations
70 papers · 4.8k indexed · 1 hit paper · h-index 36
Topics
Immune Cell Function and Interaction (11 papers)Immune Response and Inflammation (10 papers)Advanced battery technologies research (6 papers)

In The Last Decade

Zu‐Xi Yu

69 papers receiving 4.7k citations

Hit Papers

Reactive oxygen species are downstream mediators of p53-d...19962026200620161996100200300400500

Peers

Zu‐Xi Yu
Comparison fields: 5 of 128
  • Molecular Biology 2.3k
  • Immunology 1.2k
  • Physiology 630
  • Oncology 512
  • Surgery 467
Replace Jing Hua with:
Jing Hua China
Ming Zhao China
Jeong‐Ki Min South Korea
Nausicaa Clemente Italy
Shaopeng Yuan China
Satoshi Nishimura Japan
Linda M. McManus United States
Kathleen L. Gabrielson United States
Zu-Xi Yu United States
Jon D. Piganelli United States
Zu‐Xi Yu relative to Jing Hua China Jing Hua's profile →
Citations per field
00.5×1.5×
Jing Hua · 1×
Citations per year

Countries citing papers authored by Zu‐Xi Yu

Since Specialization
Citations

This map shows the geographic impact of Zu‐Xi Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zu‐Xi Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zu‐Xi Yu more than expected).

Fields of papers citing papers by Zu‐Xi Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zu‐Xi Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zu‐Xi Yu. The network helps show where Zu‐Xi Yu may publish in the future.

Co-authorship network of co-authors of Zu‐Xi Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zu‐Xi Yu. A scholar is included among the top collaborators of Zu‐Xi Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zu‐Xi Yu. Zu‐Xi Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 13
3 12
4 35
5 27
6 18
7 21
8 19
9 31
10 19
11 93
12 47
13 69
14 7
15 164
16 25
17 72
18 75
19 13
20 57

About Zu‐Xi Yu

Zu‐Xi Yu is a scholar working on Immunology, Microbiology and Toxicology, having authored 70 papers that have together received 4.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), Immune Response and Inflammation (10 papers) and Advanced battery technologies research (6 papers). The work is most often cited by research in Immunology (1.2k citations), Molecular Biology (2.3k citations) and Cancer Research (415 citations). Zu‐Xi Yu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Toren Finkel, Victor J. Ferrans, Kazuyo Takeda, V J Ferrans, Pascal J. Goldschmidt‐Clermont, Kaikobad Irani, Thomas M. Johnson, Stephen E. Epstein, Yamin Fu and Shino Nemoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026